The authors review evidence of disrupted insulin and cerebral glucose metabolism in schizophrenia, leading to increased risk of Type 2 diabetes and cardiovascular disease. They suggest that a ketogenic diet may improve both metabolic and neural stability profiles, improve cognitive function, and potentially provide symptomatic relief to people with schizophrenia while improving their cardiovascular or metabolic health. They call for controlled clinical trials to confirm or refute these findings.